Fig. 3: Time-to-relapse between responders to single vs six ketamine infusions in treatment-resistant depression. | Translational Psychiatry

Fig. 3: Time-to-relapse between responders to single vs six ketamine infusions in treatment-resistant depression.

From: A randomized, double-blind, active placebo-controlled study of efficacy, safety, and durability of repeated vs single subanesthetic ketamine for treatment-resistant depression

Fig. 3

Figure depicts Kaplan–Meier analysis of responders for up 6 months of follow-up. Relapse was defined as <50% improvement in Montgomery–Åsberg Depression Rating Scale score at that visit compared with baseline.

Back to article page